Ansa is accepting orders for synthetic DNA constructs ranging from 7.5 kb up to 50 kb for various applications.

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

Base-editing technologies along with AAV engineering not only help reduce costs but can also accelerate preclinical ...

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly ...

We talk about news in cancer, updates on COVID's origin, and business news in biotech in this episode of Touching Base.

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...